C. Lewanski

6.5k citations
41 papers · 3.0k · 1 hit paper · h-index 16

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • CAR-T cell therapy research
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Research Studies 15
    • Cancer Immunotherapy and Biomarkers 13
    • Colorectal Cancer Treatments and Studies 7
    • Cancer Treatment and Pharmacology 5
    • Lung Cancer Treatments and Mutations 22
    • Lung Cancer Diagnosis and Treatment 6

C. Lewanski

39 papers receiving 2.9k citations

Hit Papers

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial 2016 · 2.1k citations
2.1k0+3+6Years since publication50010001.5k2.0k

Peers

C. Lewanski
Comparison fields: 5 of 103
  • Oncology 2.4k
  • Pulmonary and Respiratory Medicine 1.7k
  • Immunology 587
  • Cancer Research 389
  • Radiology, Nuclear Medicine and Imaging 174
Replace Akin Atmaca with:
Akin Atmaca Germany
Bradley A. McGregor United States
Rachel E. Sanborn United States
Virginia Ferraresi Italy
S. Cedrés Spain
Yoichi Naito Japan
Asim Amin United States
Gene Grant Finley United States
Feifei Teng China
Jong‐Mu Sun South Korea
C. Lewanski relative to Akin Atmaca Germany Akin Atmaca's profile →
Citations per field
00.5×3.0×
Akin Atmaca · 1×
Citations per year

Countries citing papers authored by C. Lewanski

Since Specialization
Citations

This map shows the geographic impact of C. Lewanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Lewanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Lewanski more than expected).

Fields of papers citing papers by C. Lewanski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Lewanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Lewanski. The network helps show where C. Lewanski may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Lewanski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Lewanski Line = papers co-authored together C. Lewanski links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Hit paper breakdown →
20162112
2 2012133
3 201498
4 201665
5 199963
6 200155
7 200149
8 201831
9 201528
10 201827
11 201626
12 201622
13 201022
14 199917
15 201816
16 201616
17 201715
18 200015
19 201713
20 202012

About C. Lewanski

C. Lewanski is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 41 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Genomics and Diagnostics (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Oncology (2.4k citations), Pulmonary and Respiratory Medicine (1.7k citations), Immunology (587 citations), Cancer Research (389 citations) and Radiology, Nuclear Medicine and Imaging (174 citations). C. Lewanski has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Julien Mazières, Á. Artal, Achim Rittmeyer, Keunchil Park, Johan Vansteenkiste, Daniel Waterkamp, Marcin Kowanetz, Louis Fehrenbacher, Pei He and Marcus Ballinger. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, European Journal of Cancer, Annals of Oncology and Thorax.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact